Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.

Iorgulescu JB, Ruthen N, Ahn R, Panagioti E, Gokhale PC, Neagu M, Speranza MC, Eschle BK, Soroko KM, Piranlioglu R, Datta M, Krishnan S, Yates KB, Baker GJ, Jain RK, Suvà ML, Neuberg D, White FM, Chiocca EA, Freeman GJ, Sharpe AH, Wu CJ, Reardon DA

Open source

DOI: 10.3389/fimmu.2023.1297932
Published: 2023
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1297932,
  title = {Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.},
  author = {Iorgulescu JB and Ruthen N and Ahn R and Panagioti E and Gokhale PC and Neagu M and Speranza MC and Eschle BK and Soroko KM and Piranlioglu R and Datta M and Krishnan S and Yates KB and Baker GJ and Jain RK and Suvà ML and Neuberg D and White FM and Chiocca EA and Freeman GJ and Sharpe AH and Wu CJ and Reardon DA},
  year = {2023},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2023.1297932},
  url = {https://doi.org/10.3389/fimmu.2023.1297932}
}

RIS

TY  - JOUR
TI  - Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.
AU  - Iorgulescu JB
AU  - Ruthen N
AU  - Ahn R
AU  - Panagioti E
AU  - Gokhale PC
AU  - Neagu M
AU  - Speranza MC
AU  - Eschle BK
AU  - Soroko KM
AU  - Piranlioglu R
AU  - Datta M
AU  - Krishnan S
AU  - Yates KB
AU  - Baker GJ
AU  - Jain RK
AU  - Suvà ML
AU  - Neuberg D
AU  - White FM
AU  - Chiocca EA
AU  - Freeman GJ
AU  - Sharpe AH
AU  - Wu CJ
AU  - Reardon DA
PY  - 2023
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2023.1297932
UR  - https://doi.org/10.3389/fimmu.2023.1297932
ER  -

APA

JB, I., N, R., R, A., E, P., PC, G., M, N., MC, S., BK, E., KM, S., R, P., M, D., S, K., KB, Y., GJ, B., RK, J., ML, S., D, N., FM, W., EA, C., GJ, F., AH, S., CJ, W., & DA, R. (2023). Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2023.1297932

Source records

pubmed · retrieved 2026-09-25T11:30:36.400Z